Cholinomimetic agents and neurocognitive impairment following head injury: A systematic review

References

• Thornhill S, Teasdale GM, Murray GD, McEwen J, Roy CW, Penny KI. Disability in young people and adults one year after head injury: Prospective cohort study. British Medical Journal 2000; 320: 1631–1635
   PubMed Web of Science ®Google Scholar
• Lippert-Grüner M, Lefering R, Svestkova O. Functional outcome at 1 vs. 2 years after severe traumatic brain injury. Brain Injury 2007; 21: 1001–1005
   PubMed Web of Science ®Google Scholar
• Koponen S, Taiminen T, Portin R, Himanen L, Isoniemi H, Heinonen H, Hinkka S, Tenovuo O. Axis I and II psychiatric disorders after traumatic brain injury: A 30-year follow-up study. American Journal of Psychiatry 2002; 159: 1315–1321
   PubMed Web of Science ®Google Scholar
• Lippert-Gruner M, Kuchta J, Hellmich M, Klug N. Neurobehavioural deficits after severe traumatic brain injury (TBI). Brain Injury 2006; 20: 569–574
   PubMed Web of Science ®Google Scholar
• Salazar AM, Warden DL, Schwab K, Spector J, Braverman S, Walter J, Cole R, Rosner MM, Martin EM, Ecklund J, et al. Cognitive rehabilitation for traumatic brain injury: A randomized trial. JAMA 2000; 283: 3075–3081
   PubMed Web of Science ®Google Scholar
• Department of Health. The national service framework for long-term conditions, Available online at: www.dh.gov.uk/PublicationsAndStatistics/Publications/PublicationsPolicyAndGuidance/PublicationsPolicyAndGuidanceArticle/fs/en?CONTENT_ID=4105361&chk=jl7dri. Website accessed 20 Dec 07
   Google Scholar
• Teasdale TW, Engberg AW. Psychosocial consequences of stroke: A long-term population-based follow-up. Brain Injury 2005; 19: 1049–1058
   PubMed Web of Science ®Google Scholar
• Hayes RL, Lyeth BG, Jenkins LW. Neurochemical mechanisms of mild and moderate head injury: Implications for treatment. Mild head injury, HS Levin, HM Eisenberg, AL Benton. Oxford University Press, New York 1989; 54–79
   Google Scholar
• Arciniegas D, Adler L, Topkoff J, Cawthra E, Filley CM, Reite M. Attention and memory dysfunction after traumatic brain injury: Cholinergic mechanisms, sensory gating, and a hypothesis for further investigation. Brain Injury 1999; 13: 1–13
   PubMed Web of Science ®Google Scholar
• Chen Y, Shohami E, Constantini S, Weinstock M. Rivastigmine, a brain-selective acetylcholinesterase inhibitor, ameliorates cognitive and motor deficits induced by closed-head injury in the mouse. Journal of Neurotrauma 1998; 15: 231–237
   PubMed Web of Science ®Google Scholar
• Beerman B. Side-effects of long acting cholinesterase inhibitors. Acta Neurologica Scandinavica Supplementum 1993; 149: 53–54
   PubMedGoogle Scholar
• Cohen EL, Wurtman RJ. Brain acetylcholine: Control by dietary choline. Science 1976; 191: 561–562
   PubMed Web of Science ®Google Scholar
• Perna RB, Bordini EJ, Newman SA. Pharmacological treatments: Considerations in brain injury. Journal of Cognitive Rehabilitation 2001; 19: 4–7
   Google Scholar
• Lee HB, Lyketsos CG, Rap V. Pharmacological management of the psychiatric aspects of traumatic brain injury. International Reviews in Psychiatry 2003; 15: 359–370
   PubMed Web of Science ®Google Scholar
• Blount PJ, Nguyen CD, McDeavitt JT. Clinical use of cholinomimetic agents: A review. The Journal of Cognitive Rehabilitation 2002; 17: 314–321
   Google Scholar
• Griffin SL, van Reekum R, Masanic CA. Review of cholinergic agents in the treatment of neurobehavioral deficits following traumatic brain injury. Journal of Neuropsychiatry Clinics in Neuroscience 2003; 15: 17–26
   PubMed Web of Science ®Google Scholar
• Silver JM, Koumaras B, Chen M, Mirski D, Potkin SG, Reyes P, Warden D, Harvey PD, Archiniegas D, Katz DI, et al. Effects of rivastigmine on cognitive function in patients with traumatic brain injury. Neurology 2006; 67: 748–755
   PubMed Web of Science ®Google Scholar
• Zhang L, Plotkin RC, Wang G, Sandel ME, Lee S. Cholinergic augmentation with donepezil enhances recovery in short-term memory and sustained attention after traumatic brain injury. Archives of Physical Medicine and Rehabilitation 2004; 85: 1050–1055
   PubMed Web of Science ®Google Scholar
• Tenovuo O. Central acetylcholinesterase inhibitors in the treatment of chronic traumatic brain injury-clinical experience in 111 patients. Progress in Neuropsychopharmacology, Biology and Psychiatry 2005; 29: 61–67
   PubMed Web of Science ®Google Scholar
• Whelan FJ, Walker MS, Schultz SK. Donepezil in the treatment of cognitive dysfunction associated with traumatic brain injury. Annals of Clinical Psychiatry 2000; 12: 131–135
   PubMedGoogle Scholar
• Walker W, Seel R, Gibellato M, Lew H, Cornis-Pop M, Jena T, Silver T. The effects of Donepezil on traumatic brain injury acute rehabilitation outcomes. Brain Injury 2004; 18: 739–750
   PubMed Web of Science ®Google Scholar
• Hopewell A, Krusz JC, Thompson J. Cognitive enhancement with donepezil after TBI. Archives of Clinical Neuropsychology 2003; 18: 743
   Google Scholar
• Kaye NS, Townsend JB, 3rd, Ivins R. An open-label trial of donepezil (aricept) in the treatment of persons with mild traumatic brain injury. Journal of Neuropsychiatry Clinics in Neuroscience 2003; 15: 383–384
   PubMed Web of Science ®Google Scholar
• Nakamura T, Ikegami K, Yoshimoto K, Ozaki R. Marked improvement in disorientation in response to treatment with donepezil in patients with subacute and chronic traumatic brain injury. International Journal of Neuropsychopharma 2002; 5: S193–S194
   PubMedGoogle Scholar
• Morey CE, Cilo M, Berry J, Cusick C. The effect of Aricept in persons with persistent memory disorder following traumatic brain injury: A pilot study. Brain Injury 2003; 17: 809–815
   PubMed Web of Science ®Google Scholar
• Trovato M, Slomine B, Pidcock F, Christensen J. The efficacy of donepezil hydrochloride on memory functioning in three adolescents with severe traumatic brain injury. Brain Injury 2006; 20: 339–343
   PubMed Web of Science ®Google Scholar
• Masanic CA, Bayley MT, VanReekum R, Simard M. Open-label study of donepezil in traumatic brain injury. Archives of Physical Medicine and Rehabilitation 2001; 82: 896–901
   PubMed Web of Science ®Google Scholar
• Whitlock JA, Jr. Brain injury, cognitive impairment, and donepezil. Journal of Head Trauma Rehabilitation 1999; 14: 424–427
   PubMed Web of Science ®Google Scholar
• Taverni JP, Seliger G, Lichtman SW. Donepezil medicated memory improvement in traumatic brain injury during post acute rehabilitation. Brain Injury 1998; 12: 77–80
   PubMed Web of Science ®Google Scholar
• Cardenas DD, McLean A, Jr, Farrell-Roberts L, Baker L, Brooke M, Haselkorn J. Oral physostigmine and impaired memory in adults with brain injury. Brain Injury 1994; 8: 579–587
   PubMed Web of Science ®Google Scholar
• Levin HS, Peters BH, Kalisky Z, High WM, Jr, von Laufen A, Eisenberg HM, Morrison DP, Gary HE, Jr. Effects of oral physostigmine and lecithin on memory and attention in closed head-injured patients. Central Nervous System Trauma 1986; 3: 333–342
   PubMedGoogle Scholar
• Walton RG. Lecithin and physostigmine for posttraumatic memory and cognitive deficits. Psychosomatics 1982; 23: 435–436
   PubMed Web of Science ®Google Scholar
• Eames P, Sutton A. Protracted post-traumatic confusional state treated with physostigmine. Brain Injury 1995; 9: 729–734
   PubMed Web of Science ®Google Scholar
• Goldberg E, Gerstman LJ, Mattis S, Hughes JE, Bilder RM, Jr, Sirio CA. Effects of cholinergic treatment on posttraumatic anterograde amnesia. Archives of Neurology 1982; 39: 581
   PubMedGoogle Scholar
• Weinberg RM, Auerbach SH, Moore S. Pharmacologic treatment of cognitive deficits: A case study. Brain Injury 1987; 1: 57–59
   PubMedGoogle Scholar
• Calatayud-Maldonado V, Calatayud-Perez JB, Aso-Escario J. Effects of CDP-choline on the recovery of patients with head injury. Journal of Neurological Science 1991; 103: S15–S18
   PubMedGoogle Scholar
• Levin HS. Treatment of postconcussional symptoms with CDP-choline. Journal of Neurological Science 1991; 103: S39–S42
   PubMed Web of Science ®Google Scholar
• Leon-Carrion J, Dominguez-Roldan JM, Murillo-Cabezas F, del Rosario Dominguez-Morales M, Munoz-Sanchez MA. The role of citicholine in neuropsychological training after traumatic brain injury. Neurorehabilitation 2000; 14: 33–40
   PubMed Web of Science ®Google Scholar
• Spiers PA, Hochanadel G. Citicoline for traumatic brain injury: Report of two cases, including my own. Journal of the International Neuropsychology Society 1999; 5: 260–264
   PubMed Web of Science ®Google Scholar
• Khateb A, Ammann J, Annoni JM, Diserens K. Cognition-enhancing effects of donepezil in traumatic brain injury. European Neurology 2005; 54: 39–45
   PubMed Web of Science ®Google Scholar
• Bourgeois JA, Bahadur N, Minjares S. Donepezil for cognitive deficits following traumatic brain injury: A case report. Journal of Neuropsychiatry Clinics in Neuroscience 2002; 14: 463–464
   PubMed Web of Science ®Google Scholar
• McCrimmon S, Oddy M. Return to work following moderate-to-severe traumatic brain injury. Brain Injury 2006; 20: 1037–1046
   PubMed Web of Science ®Google Scholar
• Vesey R, Birrell JM, Bolton C, Chipperfield RS, Blackwell AD, Dening TR, Sahakian BJ. Cholinergic nicotinic systems in Alzheimer's disease: Prospects for pharmacological intervention. CNS Drugs 2002; 16: 485–500
   PubMedGoogle Scholar